BP000315-CYT-316: Recombinant Human CD-4 (203-317 a.a.)
Source: E. coli-derived.
Applications: Protein Assay; Antibody Production; WB.BP000315-CYT-315: Recombinant Human CD-4 (125-202 a.a.)
Source: E. coli-derived.
Purity > 90%, by SDS-PAGE.
Applications: Protein Assay; Antibody Production; WB.BP000315-CYT-313: Recombinant Human CD-4 (26-226 a.a.)
Source: E. coli-derived.
Applications: ELISA, Antibody Production; WB.BP000312-PRO-470: Recombinant Human CD23
Source: E. coli-derived.
Applications: ELISA; Inhibition Assays; WB.BP000309-PRO-473: Recombinant Human CRISP1
Source: E.coli-derived.
Purity > 85%, by reducing SDS-PAGE.
Applications: ELISA, WBting.BP000288-CHM-348: Recombinant Human BCA-1/BLC (CXCL13)
Source: E. coli-derived.
Determined by its ability to chemoattract human B cells using a concentration range of 1-10 ug/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000287-CHM-230: Recombinant Human MIP-5 (CCL15)
Source: E. coli-derived.
A single, non-glycosylated, polypeptide chain containing 92 amino acids and having a molecular mass of 10.1 kDa.
Determined by its ability to chemoattract human T-lymphocytes using a concentration range of 1-10 ug/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000270-CHM-376: Recombinant MIP-2 Viral
Source: E. coli-derived.
Determined by the inhibitory effect on monocyte migration response to human MIP1A using a concentration range of 1 ug/ml-10 ug/ml of viral MIP2 which will inhibit 25 ug/ml of human MIP1A.
Purity > 97%, by RP-HPLC and SDS-PAGE.BP000261-CYT-628: Recombinant Human VEGF-B (Vascular Endothelial Growth Factor B)
Source: E. coli-derived.
Measured in a cell proliferation assay using NIH-3T3 mouse embryonic fibroblast. The ED50 for this effect is < 1 ug/ml corresponding to a specific activity of less than 1,000,000 units/mg.
Purity > 90%, by SDS-PAGE.BP000259-CYT-263:Recombinant Human VEGF-E (Orf Virus)
Source: Escherichia Coli-derived.
The ED50 for stimulation of 3H-thymidine incorporation and cell proliferation by human umbilical vein endothelial cells for VEGF-E Orf Virus has been determined to be in the range of 5-20 ug/ml corresponding to a Specific Activity of 50,000-200,000 IU/mg.
Purity: > 90.0% as determined by RP-HPLC and SDS-PAGE.